ReviewBladder cancer (Amsterdam, Netherlands)2023

NK Cell-Targeted Immunotherapies in Bladder Cancer: Beyond Checkpoint Inhibitors.

Yuanshuo A Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.